- News Releases
-
- Oct. 08, 2020 (PDF/169KB)Corporate
- Sumitomo Chemical and Sumitomo Dainippon Pharma Announce Establishment and Inception of Operations of a Joint Venture Company for CDMO Business in the field of Regenerative Medicine and Cell Therapy
-
- Oct. 08, 2020 (PDF/29KB)Corporate
- Urovant Sciences Announces Co-Promotion Agreement for Vibegron with Sunovion Pharmaceuticals
-
- Oct. 06, 2020 (PDF/275KB)Products
- Sunovion Announces the Commercial Launch of KYNMOBI (apomorphine hydrochloride) Sublingual Film for the Treatment of Parkinson's Disease OFF Episodes
-
- Sep. 30, 2020 (PDF/98KB)R&D
- Myovant Sciences Announces Results of Additional Secondary Endpoint of Castration Resistance-Free Survival from Phase 3 HERO Study of Relugolix in Advanced Prostate Cancer
Other Notices
-
- Sep. 30, 2020Others
- Posted Integrated Report 2020
-
- Jun. 30, 2020Others
- Posted Factbook 2020
IR Library
-
Aiming to create innovative pharmaceutical products
-
Targeting sustainable growth
-
Leading our global expansion